Jennifer Quint, Thorax’s Journal Club editor, talks to David Jablons, University of California San Francisco, and consultant for Life Technologies, about his assay to predict survival in resected non-squamous, non-small-cell lung cancer.
See also:
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2811%2961941-7/abstract
Comments (3)
More Episodes
All Episodes>>Get this podcast on your phone, Free
